News about Market

Osstem Implant Strengthens Global Footprint with India as Key Growth Market

Osstem Implant’s success in India – one of the fastest-growing dental implant markets – is driven by a dual focus on innovation and education.

Market | 28/08/2025 | By Dineshwori |  446

Laborate's Aqualab Eyes INR 250 Crore with Retail-First Model by FY 25-26

Since its inception in 2022, Laborate’s direct-to-retail division, Aqualab, has reported consistent year-on-year growth, moving from INR 76 crore in FY 2022–23 to INR 108 crore in FY 2023–24.

Market | 27/08/2025 | By Dineshwori |  357

US EoE Market Expected to Hit USD 1.19 Billion by 2030, Driven by Next-Gen Therapies

The US market for eosinophilic esophagitis (EoE) is projected to soar from USD 202 million in 2020 to USD 1.19 billion by 2030, reflecting a compound annual growth rate (CAGR) of 19.4 percent, according to GlobalData. This substantial growth is being driven by a transition away from off-label treatments toward FDA-approved, patient-friendly therapies.

Market | 25/08/2025 | By Darshana |  147

Novo Nordisk Implements Global Hiring Freeze Amid Wegovy Pressure

Novo Nordisk, the pharmaceutical major behind the blockbuster obesity drug Wegovy, has imposed a global hiring freeze, halting recruitment for all non-critical positions. The move reflects intensifying pressure from increasing competition and market volatility.

Market | 21/08/2025 | By Darshana |  179

India's Drugs and Pharma Exports Rise 14 Percent in July

India’s exports of drugs and pharmaceuticals rose sharply in July 2025, reaching USD 2,662.24 million, up from USD 2,334.14 million in the same month last year , according to the latest trade data released by the Department of Commerce.

Market | 20/08/2025 | By Dineshwori |  229

Pharmaceutical Inspection Machines Market to Reach USD 1.66 Billion by 2030: Report

The pharmaceutical inspection machines market is undergoing rapid transformation, driven by digital transformation, regulatory pressures, and increased demand for production agility.

Market | 19/08/2025 | By Dineshwori |  139

Accord BioPharma Launches IMULDOSA Prefilled Syringes at Lowest WAC Price

Accord BioPharma has announced the commercial launch of IMULDOSA (ustekinumab-srlf), a biosimilar to STELARA (ustekinumab).

Market | 19/08/2025 | By Dineshwori |  427

Glenmark Eyes 10-15 percent India Growth by Prioritising High-Margin Branded Products

Glenmark Pharmaceuticals is targeting a compounded annual growth rate (CAGR) of 10–15 % for its India business over the next two to three years by shifting its focus up the value chain and expanding its portfolio of high-margin branded products.

Market | 19/08/2025 | By Darshana |  117

Aurobindo Pharma's China Manufacturing Plant to Reach EBITDA Break-Even by Q3 FY26

The facility began operations in late November 2024 and is currently ramping up production. With an initial annual capacity exceeding two billion units, it has already started production and invoicing between Q4 FY25 and Q1 FY26. The company has invested approximately USD 145 million in setting up the plant.

Market | 18/08/2025 | By Darshana |  209

Manufacturing and Market Risks Mount as Scorpion Capital Bets Against Soleno's PWS Therapy

The hedge fund cited issues with Vykat XR, Soleno’s recently approved treatment for Prader-Willi syndrome, citing risks of fluid accumulation in the lungs and potential heart failure. Scorpion also suggested that the drug could eventually be withdrawn from the market.

Market | 17/08/2025 | By Darshana |  217